GENZYME - THE KING OF THE BIOTECHS Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GENZYME - THE KING OF THE BIOTECHS

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Andreas Helke who wrote (308)	7/28/1998 1:38:00 PM
From: aliveinsf	Read Replies (2) of 410

AMGEN and BIOGEN have returned substantially better returns since 1985. The passbook return looks over a long period of time and takes into account peaks and valleys...I am not looking at the price at the peak but prior to the peak... Fact is, they have underperformed the other big guys...and nothing they have done in the past leads me to conclude they will do better than AMGN or BGEN....GENZ puts out press releases, gets some hype, fails to deliver and the stock goes down....it is a case of history repeating itself over and over and over...GENZ is a dog with abysmal management.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next